1. Home
  2. TFII vs AXSM Comparison

TFII vs AXSM Comparison

Compare TFII & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFI International Inc.

TFII

TFI International Inc.

HOLD

Current Price

$103.25

Market Cap

7.4B

Sector

Industrials

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$183.13

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFII
AXSM
Founded
1957
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TFII
AXSM
Price
$103.25
$183.13
Analyst Decision
Buy
Strong Buy
Analyst Count
10
20
Target Price
$112.90
$176.75
AVG Volume (30 Days)
280.4K
590.3K
Earning Date
02-18-2026
02-17-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
N/A
EPS
3.89
N/A
Revenue
$8,047,566,000.00
$561,263,000.00
Revenue This Year
N/A
$66.40
Revenue Next Year
$2.77
$56.13
P/E Ratio
$26.04
N/A
Revenue Growth
N/A
65.83
52 Week Low
$72.02
$79.19
52 Week High
$140.35
$184.40

Technical Indicators

Market Signals
Indicator
TFII
AXSM
Relative Strength Index (RSI) 58.79 79.34
Support Level $104.62 $148.14
Resistance Level $106.91 $158.56
Average True Range (ATR) 1.99 5.59
MACD -0.45 1.60
Stochastic Oscillator 22.75 96.98

Price Performance

Historical Comparison
TFII
AXSM

About TFII TFI International Inc.

TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: